SHANGHAI JUNSHI BIOSCIENCES CO., LTD. Shanghai Junshi Biosciences Co., Ltd. Stock Shanghai S.E.
Equities
688180
CNE1000041Z1
Pharmaceuticals
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 28.68 CNY | -1.04% |
|
-5.66% | -31.44% |
| Sales 2024 * | 2.13B 293M 401M | Sales 2025 * | 2.45B 338M 462M | Capitalization | 24.3B 3.35B 4.58B |
|---|---|---|---|---|---|
| Net income 2024 * | -1.43B -197M -270M | Net income 2025 * | -717M -98.75M -135M | EV / Sales 2024 * | 9.99 x |
| Net cash position 2024 * | 3.04B 419M 573M | Net cash position 2025 * | 2.38B 327M 448M | EV / Sales 2025 * | 8.95 x |
| P/E ratio 2024 * |
-6.76
x | P/E ratio 2025 * |
-9.11
x | Employees | 2,568 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 15.16% |
More Fundamentals
* Assessed data
More news
Latest transcript on Shanghai Junshi Biosciences Co., Ltd.
More press releases
More news
| 1 day | -1.04% | ||
| 1 week | -5.66% | ||
| Current month | +6.82% | ||
| 1 month | -3.47% | ||
| 3 months | -2.45% | ||
| 6 months | -32.57% | ||
| Current year | -31.44% |
1 week
28.50
29.67
1 month
26.7231.02
Current year
24.0042.60
1 year
24.0049.43
3 years
24.00131.42
5 years
24.00220.40
10 years
24.00220.40
| Managers | Title | Age | Since |
|---|---|---|---|
Jianjun Zou
CEO | Chief Executive Officer | 52 | 22-04-19 |
Zhuo Bing Zhang
FOU | Founder | 56 | 12-12-26 |
Cong Li
CEO | Chief Executive Officer | 60 | 16-12-21 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Cong Li
CEO | Chief Executive Officer | 60 | 16-12-21 |
Yi Tang
BRD | Director/Board Member | 56 | 15-05-29 |
Jun Xiong
CHM | Chairman | 50 | 15-03-26 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.55% | 1 M€ | -13.76% | - | |
| 1.13% | 45 M€ | -13.72% | - | |
| 1.13% | 45 M€ | -14.03% | - | |
| 1.13% | 35 M€ | -11.88% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-20 | 28.68 | -1.04% | 2,898,678 |
| 24-06-19 | 28.98 | -1.33% | 2,500,521 |
| 24-06-18 | 29.37 | +0.55% | 4,058,988 |
| 24-06-17 | 29.21 | +1.81% | 5,751,458 |
| 24-06-14 | 28.69 | -5.62% | 11,098,740 |
End-of-day quote Shanghai S.E., June 19, 2024
More quotes
Shanghai Junshi Biosciences Co Ltd is a China-based company mainly engaged in innovation-driven biopharmaceutical business. The Company's main businesses are the discovery, clinical research and development of innovative drugs. The Company's main products include teriprizumab injection, Etesevimab, adalimumab injection and other drugs, which are used to treat malignant tumors, autoimmune system diseases, chronic metabolic diseases, nervous system diseases and infectious diseases . The Company is also engaged in the clinical research and development of recombinant humanized anti-PCSK9 monoclonal antibody injection and other drugs. The Company provides its products for domestic and overseas markets.
Sector
Pharmaceuticals
Calendar
02:00am
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
10.7
CNY
Average target price
22.59
CNY
Spread / Average Target
+111.16%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +2.25% | 93.53B | |
| -1.71% | 38.27B | |
| -12.83% | 32.84B | |
| -12.14% | 16.08B | |
| -0.68% | 14.02B | |
| -12.63% | 11.47B | |
| +163.45% | 9.92B | |
| -53.23% | 9.42B | |
| +3.52% | 8.98B |
- Stock Market
- Equities
- 1877 Stock
- 688180 Stock
